From the Moffitt booth at #AACR26, Moffitt’s Susan Vadaparampil, PhD, MPH (
@SVadaparampil
), and Matthew Schabath, PhD, connected to discuss how advances in AI, polygenic risk scores and community outreach are shaping more precise and accessible lung cancer screening.